Global Biomarker Technologies Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 42.03 Billion |
 Market Size (Forecast Year) |
USD 122.02 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球生物标志物技术市场，按产品（耗材、仪器、服务、软件/信息学）、分析技术（色谱法、NGS、PCR、质谱法、免疫测定法）、测试类型（液体活检、固体活检）、研究领域（基因组学、蛋白质组学、代谢组学、其他研究领域）、应用（生物标志物识别、验证和开发研究、基于生物标志物的常规测试）划分 – 行业趋势和预测至 2029 年
市场分析和规模
基因表达模式被广泛用于识别各种疾病。生物标志物用于诊断各种疾病，如传染病、癌症、自身免疫性疾病等。各种疾病的患病率增加，对生物标志物技术的需求也随之增加。
- 众所周知，生物标志物具有在早期诊断疾病的能力。2021 年全球生物标志物技术市场价值为 322.034 亿美元，预计到 2029 年将达到 934.8704 亿美元，在 2022-2029 年预测期内的复合年增长率为 14.25%。Data Bridge 市场研究团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
市场定义
生物标志物是指可测量和评估为病理过程或正常生物学或对治疗干预的反应的生物特征。生物标志物广泛应用于各种疾病的诊断，例如传染病、癌症和自身免疫性疾病等。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
预测期 |
2022 - 2029 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（耗材、仪器、服务、软件/信息学）、分析技术（色谱法、NGS、PCR、质谱法、免疫测定）、测试类型（液体活检、固体活检）、研究领域（基因组学、蛋白质组学、代谢组学、其他研究领域）、应用（生物标志物识别、验证和开发研究、基于生物标志物的常规测试） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、欧洲的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others |
Biomarker Technologies Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
-
Funds and Grants
The surge in investments in the form of funds and grants for biomarker research accelerate the market growth.
-
Diagnostic Biomarker Technology
The inclination from conventional approach of pathophysiology/epidemiology to biomarker studies due to the technological advances further influence the market.
-
Prevalence of Cancer
The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarker technologies market.
Opportunities
Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, continuous product innovation will further expand the market.
Restraints/Challenges
On the other hand, the high capital investments and lengthy timelines for biomarker development are expected to obstruct market growth. Also, technical issues related to sample collection and storage are projected to challenge the biomarker technologies market in the forecast period of 2022-2029.
This biomarker technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biomarker technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Biomarker Technologies Market
Covid-19 had a positive impact on the biomarker technologies market. The increase in the number of COVID-19 accelerated the development of the biomarker technologies. Chinese research team pinpointed SARS-CoV-2 coronavirus infection from the molecular markers in the blood that are predictive of acute COVID-19. The biomarkers have become essential in clinical decision making for numerous infectious diseases treatment procedures.
Recent Development
- F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high sensitive cardiac troponin T (cTnT-hs) in April’2021. The cardiac biomarkers assist clinicians in diagnosing heart attacks and manage heart failure better.
- QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May’2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options.
Global Biomarker Technologies Market Scope and Market Size
The biomarker technologies market is segmented on the basis of product, profiling technology, test type, research area and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
- Services
- Software/Informatics
On the basis of product, the biomarker technologies market is segmented into consumables, instruments, services, and software/informatics.
Profiling Technology
- Chromatography
- NGS
- PCR
- Mass Spectrometry
- Immunoassay
On the basis of profiling technology, the biomarker technologies market is segmented into chromatography, NGS, PCR, mass spectrometry, immunoassay. Immunoassay is further sub segmented into ELISA, western blot and protein microarray.
Test Type
- Liquid Biopsy
- Solid Biopsy
On the basis of test type, the biomarker technologies market is segmented into liquid biopsy and solid biopsy. Liquid biopsy is further sub segmented into ddPCR, NGS, mass spectrometry, DHPLC and other technologies.
Research Area
- Genomics
- Proteomics
- Metabolomics
- Other Research Areas
On the basis of research area, the biomarker technologies market is segmented into genomics, proteomics, metabolomics, and other research areas. Metabolomics is further sub segmented into metabolic flux, lipidomics and others.
Application
- Biomarker Identification
- Validation and Development Research
- Routine Biomarker-Based Tests
On the basis of application, the biomarker technologies market is segmented into biomarker identification, validation and development research, routine biomarker-based tests.
Biomarker Technologies Market Regional Analysis/Insights
The biomarker technologies market is analysed and market size insights and trends are provided by country, product, profiling technology, test type, research area and application as referenced above.
The countries covered in the biomarker technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biomarker technologies market because of the rise in geriatric population, and support from private and public organizations within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in awareness related to early screening of cancer for better treatment in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biomarker technologies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomarker technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomarker technologies market. The data is available for historic period 2010-2020.
Competitive Landscape and Biomarker Technologies Market Share Analysis
The biomarker technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biomarker technologies market.
生物标志物技术市场的一些主要参与者包括 Enzo Biochem Inc.（美国）、Bio-Rad Laboratories, Inc.（美国）、Merck KGaA（德国）、PerkinElmer Inc.（美国）、QIAGEN（德国）、Agilent Technologies, Inc.（美国）、Bruker（美国）、Epigenomics AG（德国）、MESO SCALE DIAGNOSTICS, LLC（美国）、EKF Diagnostics Holdings plc（英国）、通用电气公司（美国）、Nexus-Dx（美国）、LifeSign LLC（美国）、F. Hoffmann-La Roche Ltd（瑞士）等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
